Becker's Healthcare November 27, 2024
Alexandra Murphy

Sanofi is preparing a new vaccine and biopharmaceutical manufacturing facility in Singapore, located at Tuas Biomedical Park, Bloomberg reported Nov. 27.

The plant, dubbed Modulus, represents an investment of approximately $600 million and is set to be fully operational by mid-2026.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Closing the women’s health gap: Biopharma’s untapped opportunity
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Four Opportunities To Revitalize The US Biomedical Research Enterprise
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says

Share This Article